.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Metropolis diagnostic growth significantly influenced the company\'s latest financial results for the March quarter. On Wednesday, the lab chain reported a 74 per cent rise in consolidated profit after tax. This growth resulted in a profit of Rs 50.96 crore, up from Rs 29.23 crore in the previous fiscal year. Consequently, the company demonstrated strong resilience and operational efficiency in a competitive market.
Several factors contributed to this surge, including a 23 per cent increase in year-on-year revenue. The company expanded its network to over 5,000 centres across India to meet rising diagnostic needs. Furthermore, Managing Director Surendran Chemmenkotil noted that healthy patient volumes and improved realisations drove this success. Moreover, the brand achieved these results without increasing prices during the final quarter.
Total consolidated revenue reached Rs 424.68 crore, while expenses also rose to Rs 363.19 crore. However, the operational efficiency drive offset these higher costs effectively. Therefore, the board approved a second dividend of Re 1 per share for the financial year. This decision reflects a positive outlook on the company\'s future sustainability and market position.
Q1: What drove the 74% profit increase for Metropolis Healthcare?
The growth was primarily driven by robust demand, network expansion beyond 5,000 centres, healthy patient volumes, and an improved service mix without price hikes in Q4.
Q2: What is the latest dividend announced by the company?
The board of Metropolis Healthcare has approved a second dividend of Re 1 per share for the 2025-26 financial year following its strong performance.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Metropolis Healthcare reports a 74% profit rise to Rs 50.96 cr in Q4 FY26, driven by network expansion and strong patient volumes across 5,000 centres....
5 months ago
A breakthrough peer-reviewed study demonstrates that a sequential AI diagnosis system can mirror real-world clinical reasoning. By ordering stepwise tests and updating hypotheses dynamically, this multi-agent orchestrator achieved superior diagnostic accuracy while reducing investigative costs.
Today
A prenatal case highlights severe glutaric acidemia type II presenting as bilateral hyperechoic cystic kidneys at 18 weeks. Whole-exome sequencing revealed a novel homozygous ETFDH frameshift variant, demonstrating the power of rapid genetic testing in fetal renal anomalies.
Today
Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday
This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday
A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Yesterday
